文献速递新生儿儿童神经与发育行为

33至35周早产儿缺氧缺血性脑病的全身低温治疗:一项随机临床试验

Whole-Body Hypothermia for Neonatal Encephalopathy in Preterm Infants 33 to 35 Weeks' Gestation: A Randomized Clinical Trial.
PubMed 文献 · JAMA Pediatr · 2025-01-01

这项在美国19个新生儿研究网络中心开展的随机临床试验,纳入168例33至35周胎龄、生后6小时内中重度缺氧缺血性脑病患儿,比较全身低温(33.5°C维持72小时)与常温(37°C)治疗。主要结局为18至22月龄纠正年龄时死亡或中重度残疾的复合结局,低温组35%、常温组29%(aRR 1.11,95%CI 0.74-2.00),贝叶斯分析提示低温增加死亡或残疾概率74%、增加死亡概率87%。结论认为在该人群低温未降低死亡或残疾。

要点

  • 33至35周早产儿缺氧缺血性脑病生后6小时内低温未降低18-22月龄死亡或残疾。
  • 低温组死亡或残疾35%、常温组29%,aRR 1.11(95%CI 0.74-2.00)。
  • 贝叶斯分析示低温增加死亡或残疾概率74%、增加死亡概率87%。

核心结论

  • 在33至35周胎龄缺氧缺血性脑病患儿中,生后6小时内开始的全身低温未降低18至22月龄纠正年龄时死亡或中重度残疾。
  • 贝叶斯分析提示低温增加死亡或残疾的概率为74%,增加死亡的概率为87%。

研究设计与样本

  • 随机临床试验,2015年7月至2022年12月在美国19个新生儿研究网络中心开展,预设贝叶斯和意向性分析。
  • 纳入168例33至35周胎龄、生后6小时内中重度缺氧缺血性脑病患儿,低温组88例、常温组80例。
  • 低温组维持目标食管温度33.5°C(可接受33-34°C)72小时后复温,常温组维持37°C(可接受36.5-37.3°C)。
  • 主要结局为18至22月龄纠正年龄时死亡或中重度残疾的复合结局,按脑病程度和中心校正。

主要发现

  • 低温组主要结局29/83例(35%),常温组20/69例(29%),校正相对风险1.11(95%可信区间0.74-2.00)。
  • 低温组死亡18/88例(20%),常温组9/78例(12%),校正相对风险1.38(95%可信区间0.79-2.85)。
  • 贝叶斯分析采用中性先验,显示低温增加死亡或残疾概率74%、增加死亡概率87%。

临床怎么用

  • 对33至35周胎龄缺氧缺血性脑病患儿,生后6小时内启动全身低温未显示降低死亡或残疾,临床决策需权衡个体情况。
  • 该人群应用低温治疗应参考本试验结果,不宜直接外推36周及以上胎龄的低温获益证据。

局限性

  • 原文未报告样本量计算依据、盲法实施细节及长期随访失访情况。
  • 主要结局分析基于部分随机化患儿(低温组83例、常温组69例),原文未说明排除原因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Hypothermia begun less than 6 hours after birth reduces death or disability in infants with encephalopathy due to hypoxia-ischemia at 36 or more weeks' gestation. Trials of hypothermia for infants younger than 36 weeks' gestation are lacking. OBJECTIVE: To assess the probability that hypothermia at less than 6 hours after birth decreases death or disability in infants 33 to 35 weeks' gestation with moderate or severe hypoxic-ischemic encephalopathy. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted between July 2015 and December 2022 for infants 33 to 35 weeks' gestation with moderate or severe hypoxic-ischemic encephalopathy at less than 6 hours after birth. Bayesian and intention-to-treat analyses were prespecified. The setting included 19 US Neonatal Research Network centers. Data were analyzed from March 2023 to November 2024. INTERVENTIONS: Infants received unblinded targeted esophageal temperature management. Infants with hypothermia were maintained at 33.5 °C (acceptable 33-34 °C) for 72 hours and then rewarmed. Infants with normothermia were to be maintained at 37 °C (acceptable 36.5-37.3 °C). MAIN OUTCOMES AND MEASURES: Composite of death or disability (moderate or severe) at 18 to 22 months' corrected age adjusted for level of encephalopathy and center. RESULTS: A total of 168 infants with hypothermia and normothermia were preterm (mean [SD] age, 34.0 [0.8] weeks' gestation and 34.1 [0.8] weeks' gestation, respectively), while 46 of 88 (52%) and 45 of 80 (56%) were male, respectively. Randomization occurred at mean (SD) 4.5 (1.2) hours and 4.5 (1.3) hours for the groups with hypothermia and normothermia, respectively. The primary outcome occurred in 29 of 83 infants (35%) with hypothermia and 20 of 69 infants (29%) with normothermia (adjusted relative risk [hypothermic/normothermic], 1.11; 95% credibility interval, 0.74-2.00), and death occurred in 18 of 88 infants (20%) with hypothermia and 9 of 78 infants (12%) with normothermia (adjusted relative risk, 1.38; 95% credibility interval, 0.79-2.85). Bayesian analysis with neutral prior indicated 74% probability of increased death or disability and 87% probability of increased death with hypothermia. CONCLUSIONS AND RELEVANCE: Among infants 33 to 35 weeks' gestation with hypoxic-ischemic encephalopathy, hypothermia at less than 6 hours' age did not reduce death or disability at 18 to 22 months' corrected age. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01793129.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Faix RG, Laptook AR, Shankaran S, et al. Whole-Body Hypothermia for Neonatal Encephalopathy in Preterm Infants 33 to 35 Weeks' Gestation: A Randomized Clinical Trial. JAMA Pediatr. 2025. PMID: 39992674. doi:10.1001/jamapediatrics.2024.6613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。